Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugates

被引：0
|
作者：
Satake, Noriko [1 ]
Duong, Connie [1 ]
Oestergaard, Michael [2 ]
Yoshida, Sakiko [1 ]
Chen, Cathy [1 ]
Nolta, Jan A. [3 ]
Guo, Shuling [4 ]
Seth, Punit [2 ]
Nitin, Nitin [5 ]
Tuscano, Joseph [6 ]
机构：
[1] Univ Calif Davis, Sacramento, CA USA
[2] ISIS, Carlsbad, CA USA
[3] Univ Calif Davis, Sacramento, CA 95817 USA
[4] Isis Pharmaceut Inc, Carlsbad, CA USA
[5] Univ Calif Davis, Davis, CA USA
[6] Univ Calif Davis, Ctr Canc, Sacramento, CA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate
    Satake, Noriko
    Duong, Connie
    Yoshida, Sakiko
    Oestergaard, Michael
    Chen, Cathy
    Peralta, Rachael
    Guo, Shuling
    Seth, Punit P.
    Li, Yueju
    Beckett, Laurel
    Chung, Jong
    Nolta, Jan
    Nitin, Nitin
    Tuscano, Joseph M.
    MOLECULAR MEDICINE, 2016, 22 : 632 - 642
  • [2] Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate
    Noriko Satake
    Connie Duong
    Sakiko Yoshida
    Michael Oestergaard
    Cathy Chen
    Rachael Peralta
    Shuling Guo
    Punit P Seth
    Yueju Li
    Laurel Beckett
    Jong Chung
    Jan Nolta
    Nitin Nitin
    Joseph M Tuscano
    Molecular Medicine, 2016, 22 : 632 - 642
  • [3] Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia
    Satake, Noriko
    Duong, Connie
    Chen, Cathy
    Barisone, Gustavo A.
    Diaz, Elva
    Tuscano, Joseph
    Rocke, David M.
    Nolta, Jan
    Nitin, Nitin
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (04) : 487 - 499
  • [4] Characterization of the anti-CD22 targeted therapy, moxetumomab pasudotox, for B-cell precursor acute lymphoblastic leukemia
    Kinjyo, Ichiko
    Matlawska-Wasowska, Ksenia
    Chen, Xiaoru
    Monks, Noel R.
    Burke, Patricia
    Winter, Stuart S.
    Wilson, Bridget S.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [5] The HB22.7 Anti-CD22 Monoclonal Antibody Is an Effective Platform for CD22-Targeted Antibody Drug Conjugates for Treatment of Lymphoma and Acute Lymphoblastic Leukemia
    Boyle, Soames F.
    Kato, Jason
    O'Donnell, Robert
    Tuscano, Joseph
    BLOOD, 2012, 120 (21)
  • [6] Efficacy of an Anti-CD22 Antibody-Monomethyl Auristatin E Conjugate in a Preclinical Xenograft Model of Precursor B Cell Acute Lymphoblastic Leukemia
    Yoshida, Sakiko
    Tuscano, Emily
    Duong, Connie
    Tuscano, Joseph
    Satake, Noriko
    BLOOD, 2014, 124 (21)
  • [7] Efficacy of an anti-CD22 antibody-monomethyl auristatin E conjugate in a preclinical xenograft model of precursor B-cell acute lymphoblastic leukemia
    Yoshida, Sakiko
    Tuscano, Emily
    Duong, Connie
    Chung, Jong
    Li, Yueju
    Beckett, Laurel
    Tuscano, Joseph M.
    Satake, Noriko
    LEUKEMIA & LYMPHOMA, 2017, 58 (05) : 1254 - 1257
  • [8] The Role of MXD3 in Human Precursor B Cell Acute Lymphoblastic Leukemia
    Barisone, Gustavo
    Satake, Noriko
    Lewis, Carly
    Lam, Kit
    Nolta, Jan A.
    Diaz, Elva
    BLOOD, 2012, 120 (21)
  • [9] The Role of MXD3 in Human Precursor B cell Acute Lymphoblastic Leukemia.
    Barisone, G.
    Satake, N.
    Lewis, C.
    Lam, K.
    Nolta, J.
    Diaz, E.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [10] Efficacy of a CD22-targeted antibody-saporin conjugate in a xenograft model of precursor-B cell acute lymphoblastic leukemia
    Kato, Jason
    Satake, Noriko
    O'Donnell, Robert T.
    Abuhay, Mastewal
    Lewis, Carly
    Tuscano, Joseph M.
    LEUKEMIA RESEARCH, 2013, 37 (01) : 83 - 88
12345